ESSENTIA.NS
ESSENTIA · Corporate filings
NSE
Financial Charts & Report quarterly revenue, profit, margins, growth, and price overlay
Stock market charts for ESSENTIA.NS quarterly results: revenue, profit, margins, growth, and filing-derived operating metrics.
Loading financial charts...
Results Change Summary quarter-on-quarter and year-on-year filing evidence
Generate an evidence-linked summary of revenue, margin, profit, debt, cash and operating cash flow changes.
Financial Results figures in ₹ crore, except EPS/%
Loading…
Relative Returns vs Sector, Nifty 50, Sensex, Nifty 500
Loading…
CAN SLIM William O'Neil's growth-stock criteria
Loading…
Latest Shareholding Pattern promoter, FII, DII, public and institution trend
NSE synced data
Corporate Governance SEBI integrated governance filing
NSE synced data
Loading governance disclosure...
Announcements
Certificate under SEBI (Depositories and Participants) Regulations, 2018
15 Jul 2026
Outcome of Board Meeting
09 Jul 2026
Outcome of Board Meeting
09 Jul 2026
Trading Window
27 Jun 2026
Clarification - Financial Results
22 Jun 2026
Copy of Newspaper Publication
13 Jun 2026
General Updates
12 Jun 2026
General Updates
30 May 2026
Outcome of Board Meeting
29 May 2026
General Updates
29 May 2026
Copy of Newspaper Publication
26 May 2026
Record Date
15 May 2026
Rights Issue
15 May 2026
Change in Company Secretary/Compliance Officer
02 May 2026
Outcome of Board Meeting
02 May 2026
News
Loading…
Corporate Actions dividends, bonuses, splits, buybacks, rights
Rights 161:250 @ Premium Re 0.45 /-
Rights 161:250 @ Premium Re 0.45 /-
Ex-date: 20 May 2026
Annual General Meeting
Annual General Meeting
Ex-date: 20 Sep 2024
Rights 20:119 @ Premium Rs 2.25/-
Rights 20:119 @ Premium Rs 2.25/-
Ex-date: 31 May 2024
Bonus 1:1
Bonus 1:1
Ex-date: 11 Jan 2024
Annual General Meeting
Annual General Meeting
Ex-date: 28 Aug 2023
Rights 37:200 @ Premium Rs 6/-
Rights 37:200 @ Premium Rs 6/-
Ex-date: 17 Nov 2022
Annual General Meeting
Annual General Meeting
Ex-date: 02 Sep 2022
Rights 33:13@ Premium Rs 0.80/-
Rights 33:13@ Premium Rs 0.80/-
Ex-date: 04 May 2022
Face Value Split (Sub-Division) - From Rs 3/- Per Share To Re 1/- Per Share
Face Value Split (Sub-Division) - From Rs 3/- Per Share To Re 1/- Per Share
Ex-date: 03 Feb 2022
Annual General Meeting
Annual General Meeting
Ex-date: 22 Sep 2021
Annual General Meeting
Annual General Meeting
Ex-date: 18 Sep 2020
Annual General Meeting
Annual General Meeting
Ex-date: 12 Sep 2019
Annual General Meeting
Annual General Meeting
Ex-date: 12 Sep 2018
Annual General Meeting
Annual General Meeting
Ex-date: 14 Sep 2017
Annual General Meeting
Annual General Meeting
Ex-date: 15 Sep 2016
Annual General Meeting
Annual General Meeting
Ex-date: 18 Sep 2015
Annual General Meeting
Annual General Meeting
Ex-date: 11 Sep 2014
Annual General Meeting
Annual General Meeting
Ex-date: 12 Nov 2013
Board Meetings
28 May 2026
To consider and approve the financial results for the period ended March 31, 2026 and other business matters
28 May 2026
INTEGRA ESSENTIA LIMITED has informed the Exchange about Board Meeting to be held on 28-May-2026 to consider and approve the Quarterly Audited Financial results of the Company for the period ended March 2026 and Other business.
28 May 2026
To consider and approve the financial results for the period ended March 31, 2026 and other business matters
14 May 2026
to consider and approve matters relating to the proposed Rights Issue of the Company,
10 Jan 2026
INTEGRA ESSENTIA LIMITED has informed the Exchange about Board Meeting to be held on 10-Jan-2026 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended December 2025 and Fund raising.
10 Jan 2026
To consider and approve the financial results for the period ended December 31, 2025, Fund Raising and other business matters
29 Oct 2025
To consider and approve the financial results for the period ended September 30, 2025
29 Oct 2025
INTEGRA ESSENTIA LIMITED has informed the Exchange about Board Meeting to be held on 29-Oct-2025 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2025 .